Expression of O6-Methylguanine-DNA Methyltransferase Examined by Alkyl-Transfer Assays, Methylation-Specific PCR and Western Blots in Tumors and Matched Normal Tissue.

Kimiko Ishiguro, Krishnamurthy Shyam, Philip G Penketh, Raymond P Baumann, Alan C Sartorelli, Thomas J Rutherford, Elena S Ratner
{"title":"Expression of <i>O</i><sup>6</sup>-Methylguanine-DNA Methyltransferase Examined by Alkyl-Transfer Assays, Methylation-Specific PCR and Western Blots in Tumors and Matched Normal Tissue.","authors":"Kimiko Ishiguro,&nbsp;Krishnamurthy Shyam,&nbsp;Philip G Penketh,&nbsp;Raymond P Baumann,&nbsp;Alan C Sartorelli,&nbsp;Thomas J Rutherford,&nbsp;Elena S Ratner","doi":"10.4236/jct.2013.44103","DOIUrl":null,"url":null,"abstract":"<p><p>The tumor selectivity of alkylating agents that produce guanine <i>O</i><sup>6</sup>-chloroethyl (laromustine and carmustine) and <i>O</i><sup>6</sup>-methyl (temozolomide) lesions, depends upon <i>O</i><sup>6</sup>-methylguanine-DNA methyltransferase (MGMT) activity being lower in tumor than in host tissue. Despite the established role of MGMT as a tumor resistance factor, consensus on how to assess MGMT expression in clinical samples is unsettled. The aim of this study is to examine the relationship between the values derived from distinctive MGMT measurements in 13, 12, 6 and 2 pairs of human tumors and matched normal adjacent tissue from the colon, kidney, lung and liver, respectively, and in human cell lines. The MGMT measurements included (a) alkyl-transfer assays using [benzene-<sup>3</sup>H]<i>O</i><sup>6</sup>-benzylguanine as a substrate to assess functional MGMT activity, (b) methylation-specific PCR (MSP) to probe <i>MGMT</i> gene promoter CpG methylations as a measure of gene silencing, and (c) western immunoblots to analyze the MGMT protein. In human cell lines, a strict negative correlation existed between MGMT activity and the extent of promoter methylation. In tissue specimens, by contrast, the correlation between these two variables was low. Moreover, alkyl-transfer assays identified 3 pairs of tumors and normal tissue with tumor-selective reduction in MGMT activity in the absence of promoter methylation. Cell line MGMT migrated as a single band in western analyses, whereas tissue MGMT was heterogeneous around its molecular size and at much higher molecular masses, indicative of multi-layered post-translational modifications. Malignancy is occasionally associated with a mobility shift in MGMT. Contrary to the prevalent expectation that MGMT expression is governed at the level of gene silencing, these data suggest that other mechanisms that can lead to tumor-selective reduction in MGMT activity exist in human tissue.</p>","PeriodicalId":15267,"journal":{"name":"Journal of Cancer Therapy","volume":"4 4","pages":"919-931"},"PeriodicalIF":0.0000,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4236/jct.2013.44103","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4236/jct.2013.44103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12

Abstract

The tumor selectivity of alkylating agents that produce guanine O6-chloroethyl (laromustine and carmustine) and O6-methyl (temozolomide) lesions, depends upon O6-methylguanine-DNA methyltransferase (MGMT) activity being lower in tumor than in host tissue. Despite the established role of MGMT as a tumor resistance factor, consensus on how to assess MGMT expression in clinical samples is unsettled. The aim of this study is to examine the relationship between the values derived from distinctive MGMT measurements in 13, 12, 6 and 2 pairs of human tumors and matched normal adjacent tissue from the colon, kidney, lung and liver, respectively, and in human cell lines. The MGMT measurements included (a) alkyl-transfer assays using [benzene-3H]O6-benzylguanine as a substrate to assess functional MGMT activity, (b) methylation-specific PCR (MSP) to probe MGMT gene promoter CpG methylations as a measure of gene silencing, and (c) western immunoblots to analyze the MGMT protein. In human cell lines, a strict negative correlation existed between MGMT activity and the extent of promoter methylation. In tissue specimens, by contrast, the correlation between these two variables was low. Moreover, alkyl-transfer assays identified 3 pairs of tumors and normal tissue with tumor-selective reduction in MGMT activity in the absence of promoter methylation. Cell line MGMT migrated as a single band in western analyses, whereas tissue MGMT was heterogeneous around its molecular size and at much higher molecular masses, indicative of multi-layered post-translational modifications. Malignancy is occasionally associated with a mobility shift in MGMT. Contrary to the prevalent expectation that MGMT expression is governed at the level of gene silencing, these data suggest that other mechanisms that can lead to tumor-selective reduction in MGMT activity exist in human tissue.

用烷基转移法、甲基化特异性PCR和Western Blots检测o6 -甲基鸟嘌呤- dna甲基转移酶在肿瘤和匹配正常组织中的表达
产生鸟嘌呤o6 -氯乙基(拉莫司汀和卡莫司汀)和o6 -甲基(替莫唑胺)病变的烷基化剂的肿瘤选择性取决于肿瘤中o6 -甲基鸟嘌呤- dna甲基转移酶(MGMT)活性低于宿主组织。尽管MGMT作为肿瘤抵抗因子的作用已经确立,但如何评估临床样本中MGMT表达的共识尚未达成。本研究的目的是检验在13对、12对、6对和2对人类肿瘤和分别来自结肠、肾脏、肺和肝的正常邻近组织以及人类细胞系中不同的MGMT测量值之间的关系。MGMT检测包括(a)以[苯- 3h] o6 -苄基鸟嘌呤为底物的烷基转移检测,以评估MGMT功能活性;(b)甲基化特异性PCR (MSP)检测MGMT基因启动子CpG甲基化,以测量基因沉默;(c) western免疫印迹检测MGMT蛋白。在人类细胞系中,MGMT活性与启动子甲基化程度之间存在严格的负相关。相比之下,在组织标本中,这两个变量之间的相关性很低。此外,烷基转移实验鉴定了3对肿瘤和正常组织在没有启动子甲基化的情况下MGMT活性的肿瘤选择性降低。在western分析中,细胞系MGMT作为单条带迁移,而组织MGMT在其分子大小和更高的分子质量上是异质的,表明存在多层翻译后修饰。恶性肿瘤有时与MGMT的移动性转移有关。与MGMT表达受基因沉默水平控制的普遍预期相反,这些数据表明,在人体组织中存在导致MGMT活性肿瘤选择性降低的其他机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信